Friday, 26 April 2024
  
Login

Australia's most trusted
source of pharma news

Friday, 26 April 2024
Ascott 2
Ascott 2
CEO pay plummets 87%

In what's likely to be the biggest comedown in CEO salaries reported this year, this pharma boss saw his remuneration package drop through the floor - by 87 per cent - but it had nothing to do with his performance.

Drs don't have time for rep visits
ICYMI: The stories that topped this week
TODAY Your Week in Five Minutes
Salary hikes hit a speed bump
New figures reveal modest increases amid tight budgets
TODAY
Now that's big: Lilly raises the bar
Revenue from one drug to equal entire sales from 2023
TODAY
HPG
HPG
GM: 'Hardest decision of my life'
Aussie MD to step down after 22yrs at the same company
24 April
AbbVie considered 'the Best' by far
How HCPs in immunology ranked pharma companies
24 April
Pharma headhunting gone wrong
Some approaches are driving prospective hires away
23 April
Why doctors aren't seeing reps
How often HCPs see reps and why it's not more often
22 April
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (4)

Sales & Customer Relations (27)

Clinical & Medical, R&D (11)

Regulatory, Pharmacovigilance & QA (7)

Devices (1)

Other (20)

MA CEO hails vaccine report
Reinforces calls to lower the discount rate for vaccines
TODAY
Omico snags new partner
Expanding its reach to Queensland cancer patients
TODAY
Who's the TGA taking to court?
NRL team tapes over front-of-jersey sponsor on legal advice
24 April
New life for used blister packs
Surprise transformation for recycled pharma packaging waste
24 April
Boost for potential blockbuster
Combo increases median survival by two-thirds in prostate cancer
24 April
Company looks beyond the ASX
Opportunities with Haleon open up under global growth strategy
24 April
Who's the new AusBiotech CEO?
Well-known company leader takes top industry role
23 April
Why this pharmacy is a 'champion'
Beats a tough field to take out national recognition
23 April
New hope for Roche's PD drug
Post hoc analysis of data shows potential in a subset of patients
23 April
GSK shores up massive market
Long-term trial data could stave off upcoming rivals
23 April
Gilead backs 2030 hepatitis goal
Throws down $400,000 to help achieve elimination
23 April
Ex PM-staffer nabbed by RCA
Joins the board along with successful IT entrepreneur
22 April
Flu vax program wins a boost
Pharmacists to go off-site ahead of 'nasty' flu season
22 April
PBS listings take the slow lane
Drugs waiting longer for subsidy after PBAC recommendation
22 April
PiF jobs
PiF jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.